Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Dummer R, Robert C, Scolyer RA, Taube JM, et al. Neoadjuvant anti-PD-1 alone or in combination with anti-TIGIT or an oncolytic virus in resectable stage IIIB-D melanoma: a phase 1/2 trial. Nat Med 2025 Jan 7. doi: 10.1038/s41591-024-03411.
PMID: 39775043


Privacy Policy